These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 36826096)

  • 1. Management of Marginal Zone Lymphoma: A Canadian Perspective.
    Peters A; Keating MM; Nikonova A; Doucette S; Prica A
    Curr Oncol; 2023 Feb; 30(2):1745-1759. PubMed ID: 36826096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
    Cheah CY; Opat S; Trotman J; Marlton P
    Intern Med J; 2019 Sep; 49(9):1070-1080. PubMed ID: 30816618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.
    Ayyappan S; William BM
    Curr Oncol Rep; 2018 Mar; 20(4):33. PubMed ID: 29572581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of nodal and primary splenic marginal zone lymphoma.
    Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
    Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
    [No Abstract]   [Full Text] [Related]  

  • 6. Marginal Zone Lymphoma: State-of-the-Art Treatment.
    Sindel A; Al-Juhaishi T; Yazbeck V
    Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Treatments in Marginal Zone Lymphoma.
    Alderuccio JP; Kahl BS
    Oncology (Williston Park); 2022 Apr; 36(4):206-215. PubMed ID: 35436062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.
    Grunenberg A; Kaiser LM; Woelfle S; Schmelzle B; Viardot A; Möller P; Barth TFE; Muche R; Dreyhaupt J; Raderer M; Kiesewetter B; Buske C
    BMC Cancer; 2021 Jun; 21(1):749. PubMed ID: 34187401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal zone B-cell lymphomas.
    Sagaert X; Tousseyn T
    Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
    Joshi M; Sheikh H; Abbi K; Long S; Sharma K; Tulchinsky M; Epner E
    Ther Adv Hematol; 2012 Oct; 3(5):275-90. PubMed ID: 23616915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
    Lasica M; Anderson MA; Boussioutas A; Gregory GP; Hamad N; Manos K; McKelvie P; Ng M; Campbell B; Palfreyman E; Salvaris R; Weinkove R; Wight J; Opat S; Tam C
    Intern Med J; 2024 Jun; 54(6):1017-1030. PubMed ID: 38881453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective management strategies for patients with marginal zone lymphoma.
    Rosand CB; Valla K; Flowers CR; Koff JL
    Future Oncol; 2018 May; 14(12):1213-1222. PubMed ID: 29260925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.
    Nakamura S; Ponzoni M
    Pathology; 2020 Jan; 52(1):15-29. PubMed ID: 31757436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal zone lymphomas.
    Zucca E; Rossi D; Bertoni F
    Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.